Literature DB >> 12823395

Comparison of cadaveric pericardial, dermal, vein, and synthetic grafts for tunica albuginea substitution using a rat model.

S Leungwattanakij1, T J Bivalacqua, D-Y Yang, J-S Hyun, W J G Hellstrom.   

Abstract

OBJECTIVE: To evaluate in an animal model the intermediate and long-term efficacy of cadaveric pericardium, dermis, vein and Gore-Tex per thousand as grafting materials for tunica albuginea substitution after plaque excision for Peyronie's disease.
MATERIALS AND METHODS: The study comprised 100 male Sprague-Dawley rats (300-325 g) divided into five equal groups: group 1, sham-operated controls; and groups 2-5 which underwent wedge excision of the tunica albuginea and replacement with either cadaveric pericardium, dermis, vein or Gore-Tex grafts. Ten rats in each group had the cavernosal nerve stimulated electrically to assess erectile function at 4 months, and the remaining 10 rats at 6 months. After death the sampled tissues were fixed in 10% formalin, paraffin-embedded, and stained with Masson's trichrome and Verhoff's van Giesen for collagen and elastic fibres.
RESULTS: Erectile function, assessed by cavernosal nerve stimulation, did not differ significantly in any of the groups (P > 0.05). The histological assessment of penile cross-sections showed minimal fibrosis surrounding the patch in the dermal and vein grafts, and moderate to severe fibrosis in the Gore-Tex graft at 4 and 6 months. In the pericardial graft there was a moderate degree of fibrosis at 4 months with only minimal fibrosis at 6 months.
CONCLUSIONS: These results show that cadaveric pericardium allows complete penile expansion and is strong enough to withstand normal intracorporal pressures. There was minimal fibrosis in the pericardial, dermal and vein grafts, and moderate fibrosis in the Gore-Tex graft at 6 months. The pericardial graft is a satisfactory grafting material when used for tunica albuginea substitution, including the surgical management of Peyronie's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823395     DOI: 10.1046/j.1464-410x.2003.04279.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  8 in total

1.  Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction.

Authors:  Limin Ma; Yijun Yang; Suresh C Sikka; Philip J Kadowitz; Louis J Ignarro; Asim B Abdel-Mageed; Wayne J G Hellstrom
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

Review 2.  [Use of free dermal grafts in urology].

Authors:  H Sperling; G Lümmen; S Krege; H Rübben
Journal:  Urologe A       Date:  2005-07       Impact factor: 0.639

3.  Long-term results of the surgical treatment of Peyronie's disease with Egydio's technique: a European multicentre study.

Authors:  Salvatore Sansalone; Giulio Garaffa; Rados Djinovic; Stefano Pecoraro; Mauro Silvani; Guido Barbagli; Alessandro Zucchi; Giuseppe Vespasiani; Carla Loreto
Journal:  Asian J Androl       Date:  2011-07-11       Impact factor: 3.285

Review 4.  Peyronie's surgery: graft choices and outcomes.

Authors:  Aaron C Lentz; Culley C Carson
Journal:  Curr Urol Rep       Date:  2009-11       Impact factor: 3.092

Review 5.  Modern treatment strategies for penile prosthetics in Peyronie's disease: a contemporary clinical review.

Authors:  Matthew J Ziegelmann; M Ryan Farrell; Laurence A Levine
Journal:  Asian J Androl       Date:  2020 Jan-Feb       Impact factor: 3.285

6.  Peyronie's reconstruction for maximum length and girth gain: geometrical principles.

Authors:  Paulo H Egydio; Salvatore Sansalone
Journal:  Adv Urol       Date:  2008-12-03

Review 7.  Peyronie's disease: current therapy.

Authors:  Clay M Pendleton; Run Wang
Journal:  Transl Androl Urol       Date:  2013-03

8.  Evaluation of Bi-Layer Silk Fibroin Grafts for Penile Tunica Albuginea Repair in a Rabbit Corporoplasty Model.

Authors:  Gokhan Gundogdu; Zhamshid Okhunov; Stephanie Starek; Faith Veneri; Hazem Orabi; Sarah A Holzman; Maryrose P Sullivan; Antoine E Khoury; Joshua R Mauney
Journal:  Front Bioeng Biotechnol       Date:  2021-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.